Dow Down0.05% Nasdaq Up0.31%

Protalix BioTherapeutics, Inc. (PLX)

-NYSE MKT
2.07 Down 0.03(1.43%) 10:21AM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 3,707   2,686   7,383   1,122  
Cost of Revenue1,798  1,605  4,073  1,552  
Gross Profit 1,909   1,081   3,310   (430)
Operating Expenses
Research Development6,105  4,962  6,067  7,398  
Selling General and Administrative2,012  1,566  3,711  2,320  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (6,208) (5,447) (6,468) (10,148)
Income from Continuing Operations
Total Other Income/Expenses Net(101)202  38  (890)
Earnings Before Interest And Taxes(6,309)(5,245)(6,430)(11,038)
Interest Expense1,701  874  915  (153)
Income Before Tax(8,010)(6,119)(7,345)(10,885)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,010)(6,119)(7,345)(10,885)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,010) (6,119) (7,345) (10,885)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,010) (6,119) (7,345) (10,885)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.